Gizmodo

[Only registered and activated users can see links. Click Here To Register...][Only registered and activated users can see links. Click Here To Register...], the UK-based maker of popular inhalers like Symbicort and Airsupra, announced Monday it plans to cap costs for patients using its inhalers in the U.S. at $35 per month starting June 1. The inhalers treat [Only registered and activated users can see links. Click Here To Register...] and chronic obstructive pulmonary disease, which combined affect roughly 41 million Americans…
[Only registered and activated users can see links. Click Here To Register...]


[Only registered and activated users can see links. Click Here To Register...]